Wednesday, June 16, 2021

Recoveries outnumber daily Covid-19 cases, over two crore recovered so far – ET HealthWorld


India‘s daily Covid-19 recoveries have outnumbered the daily new cases, taking the total recoveries to over two crore, the Union Health Ministry said on Friday.

This is the third time in the last four days that recoveries have outnumbered daily cases.

India’s cumulative recoveries have surpassed 2 crore (2,00,79,599) with 3,44,776 patients recuperating in a day.

“It outnumbers India’s daily new Covid cases for the third time in the last four days,” the ministry said, adding ten states account for 71.16 percent of the new recoveries.

A total of 3,43,144 new coronavirus infections were registered in a day.

Maharashtra has reported the highest daily new cases at 42,582. It is followed by Kerala with 39,955 while Karnataka reported 35,297 new cases.

The cumulative tests conducted in the country for detection of Covid-19 stands over 31 crore, and the cumulative positivity rate has also marginally increased to 7.72 percent. However, the daily positivity rate slightly declined to 20.08 percent, the ministry said.

India’s total active caseload has decreased to 37,04,893 and now comprises 15.41 percent of the country’s total cases.

A net decline of 5,632 cases has been recorded in the active caseload in a span of 24 hours.

The National Mortality Rate currently stands at 1.09 percent, the ministry said.

A total of 4,000 deaths were reported in a span of 24 hours.

Ten states account for 72.70 percent of the new deaths. Maharashtra saw the maximum casualties (850). Karnataka follows with 344 daily deaths.

The cumulative number of Covid-19 vaccine doses administered in the country is nearing 18 crore, the ministry said.

A total of 17,92,98,584 vaccine doses have been administered through 26,02,435 sessions, according to the provisional report till 7 am.

These include 96,18,127 healthcare workers (HCWs) who have taken the first dose and 66,04,549 HCWs who have taken the second dose, 1,43,22,390 FLWs who have received the first dose, 81,16,153 FLWs who have received the second dose and 39,26,334 beneficiaries in the 18-45 years age group who have taken the first dose.

Besides, 5,66,09,783 and 85,39,763 beneficiaries aged 45 to 60 years have been administered the first and second dose respectively, while 5,42,42,792 and 1,73,18,693 beneficiaries of more than 60 years old have taken the first and second dose.

The ministry said 4,40,706 beneficiaries in the age group of 18-44 years have received their first dose of Covid vaccine in the last 24 hours and cumulatively 39,26,334 across 32 states and UTs since the start of phase-3 of vaccination drive.

More than 20 lakh vaccination doses were administered in a span of 24 hours.

As on Day-118 of the vaccination drive (May 13), 20,27,162 vaccine doses were given. Across 18,624 sessions, 10,34,304 beneficiaries were vaccinated for the first dose and 9,92,858 beneficiaries received their second dose of vaccine.

The Centre also said that cumulatively, 9,294 oxygen concentrators; 11,835 oxygen cylinders; 19 oxygen generation plants; 6,439 ventilators/Bi PAP and nearly 4.22 L Remdesivir vials have been delivered or dispatched through road and air.





Source link

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

J&J exec urges industry to start thinking ‘cure’ in cancer

Amid COVID-19 lockdowns, routine cancer screenings were put on the back burner. While that may be short-term harm from the pandemic, the crisis also...

Regeneron’s COVID-19 antibodies breach a new frontier by cutting deaths in some hospitalized patients

Antibody treatments have shown little success in helping COVID-19 patients with severe disease. But a large study of hospitalized patients reveals that Regeneron’s antibody...

Bharat Biotech supplies Covaxin to 16 states

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.Company's...

US’ Centers for Disease Control calls coronavirus Delta variant a ‘variant of concern’

The US Centers for Disease Control and Prevention now called the Delta variant of the novel coronavirus, also known as B.1.617.2, a "variant of...

Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen

Novartis and Amgen were the first onto the CGRP scene with migraine drug Aimovig, but tensions ensued shortly into the drug's launch as both...